These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3429895)

  • 21. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of renal lithiasis.
    Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
    Scand J Urol Nephrol; 2003; 37(6):482-6. PubMed ID: 14675921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria.
    Grujic D; Salido EC; Shenoy BC; Langman CB; McGrath ME; Patel RJ; Rashid A; Mandapati S; Jung CW; Margolin AL
    Am J Nephrol; 2009; 29(2):86-93. PubMed ID: 18698135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histopathologic study of experimental nephrocalcinosis induced by ethylene glycol].
    Miján Ortiz JL; Zuluaga Gómez A; Aneiros Cachaza J; Torres Ramírez C; De la Fuente Serrano A
    Actas Urol Esp; 1987; 11(6):648-51. PubMed ID: 3452999
    [No Abstract]   [Full Text] [Related]  

  • 27. Critical clue to ethylene glycol poisoning.
    Huhn KM; Rosenberg FM
    CMAJ; 1995 Jan; 152(2):193-5. PubMed ID: 7820801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental oxalo calcic nephrolithiasis and nephrocalcinosis induced by ethylene glycol].
    Rodríguez-miñón Cifuentes JL
    Actas Urol Esp; 1977; 1(1):39-44. PubMed ID: 878931
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antilithogenic action of dehydroxymaleic, ketomalonic (mesoxalic) and tartronic acids in relation to experimental lithiasis in rats].
    Thomas J; Thomas E; Rinjard P; Steg A
    Ann Urol (Paris); 1989; 23(5):444-52. PubMed ID: 2624451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals.
    de Water R; Boevé ER; van Miert PP; Deng G; Cao LC; Stijnen T; de Bruijn WC; Schröder FH
    Scanning Microsc; 1996; 10(2):591-601; discussion 601-3. PubMed ID: 9813634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation.
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; van 't Noordende JM; Schrder FH
    Scanning Microsc; 1995 Mar; 9(1):115-24; discussion 124-5. PubMed ID: 8553010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in calcium oxalate crystal, morphology as a function of concentration.
    Burns JR; Finlayson B
    Invest Urol; 1980 Sep; 18(2):174-7. PubMed ID: 7410034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium oxalate crystals in fetal bovine serum: implications for cell culture, phagocytosis and biomineralization studies in vitro.
    Pedraza CE; Chien YC; McKee MD
    J Cell Biochem; 2008 Apr; 103(5):1379-93. PubMed ID: 17879965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in MDCK and LLC-PK1 cells exposed to oxalate and calcium oxalate monohydrate crystals.
    Hackett RL; Shevock PN; Khan SR
    Scanning Microsc; 1995 Jun; 9(2):587-96. PubMed ID: 8714751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylene blue and other agents as inhibitors of calcium oxalithiasis in vivo.
    van't Riet B; O'Rear CE; Smith MJ
    Invest Urol; 1978 Nov; 16(3):201-3. PubMed ID: 101482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature.
    Thongboonkerd V; Semangoen T; Chutipongtanate S
    Clin Chim Acta; 2006 May; 367(1-2):120-31. PubMed ID: 16458875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An experimental study of effect of different extracts of Alisma orientalis on urinary calcium oxalate stones formation in rats].
    Cao ZG; Liu JH; Radman AM; Wu JZ; Ying CP; Zhou SW
    Zhongguo Zhong Yao Za Zhi; 2003 Nov; 28(11):1072-5. PubMed ID: 15615421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphological effects of glycosaminoglycans on calcium oxalate monohydrate crystals.
    Shirane Y; Kurokawa Y; Sumiyoshi Y; Kagawa S
    Scanning Microsc; 1995; 9(4):1081-8; discussion 1088. PubMed ID: 8819889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active renal crystal clearance in rats and humans.
    Vervaet BA; Verhulst A; Dauwe SE; De Broe ME; D'Haese PC
    Kidney Int; 2009 Jun; 75(12):1357-1358. PubMed ID: 19483756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.